Literature DB >> 23836613

Enantiomeric separation of citalopram base by supercritical fluid chromatography.

Min Li1, Zongbi Bao, Baogen Su, Huabin Xing, Yiwen Yang, Qilong Ren.   

Abstract

The chiral separation of citalopram base by supercritical fluid chromatography on a semipreparative Chiralpak AD column was studied with the use of three alcohol-type modifiers (methanol, ethanol, and 2-propanol) with different volume percentages (5, 10, and 15%). The best separation was achieved when 10% 2-propanol was used in the presence of 0.1% diethylamine as additive. Under these conditions, the resolution reached 2.15 and the selectivity was 1.388. In addition, other parameters that affected the retention and separation properties, i.e. temperature, pressure, and density, were studied in detail. At the same pressure, a decrease in the temperature improved the enantioselectivity as the experimental temperature range was below the isoelution temperature. However, the temperature dependence of the retention factor was complicated. As a rule, the retention factor decreased when the temperature increased at the same density. A satisfactory regression of the logarithm of the retention factor versus density and temperature was obtained using a simplified lattice-fluid model. Surprisingly, the relationship between the Henry constant and density can be accurately correlated by using the same quadratic equation.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Chiralpak AD; Citalopram; Enantioseparation; Henry constant; Supercritical fluid chromatography

Mesh:

Substances:

Year:  2013        PMID: 23836613     DOI: 10.1002/jssc.201300503

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Enantioseparation of Citalopram by RP-HPLC, Using Sulfobutyl Ether-β-Cyclodextrin as a Chiral Mobile Phase Additive.

Authors:  Yangfeng Peng; Quan Sophia He; Jiang Cai
Journal:  Int J Anal Chem       Date:  2016-01-05       Impact factor: 1.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.